Finally, the KRAS level was different in the PTEN-WT and PTEN-mut cohorts, but no difference was found in the EGFR level, implying that the effect of PTEN on KRAS-mutant and EGFR-mutant cancers is different (Fig. 6E). The gene discussed is EGFR; the disease is cancer.